Yarrow Bioscience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell YARW and other ETFs, options, and stocks.

About YARW

Yarrow Bioscience, Inc. is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. The company is developing YB-101, a potentially first-of-its-kind antibody therapy aimed at treating Graves disease (GD) and thyroid eye disease (TED). 

CEO
Rebecca Velez Frey, PharmD
CEORebecca Velez Frey, PharmD
Employees
10
Employees10
Headquarters
New Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded
Founded
Employees
10
Employees10

YARW Key Statistics

Market cap
23.71M
Market cap23.71M
Price-Earnings ratio
-1.31
Price-Earnings ratio-1.31
Dividend yield
Dividend yield
Average volume
43.41K
Average volume43.41K
High today
$35.96
High today$35.96
Low today
$31.55
Low today$31.55
Open price
$31.55
Open price$31.55
Volume
18.48K
Volume18.48K
52 Week high
$46.95
52 Week high$46.95
52 Week low
$14.03
52 Week low$14.03

Stock Snapshot

The current Yarrow Bioscience(YARW) stock price is $34.40, with a market capitalization of 23.71M. The stock trades at a price-to-earnings (P/E) ratio of -1.31.

As of 2026-08-03, Yarrow Bioscience(YARW) stock has fluctuated between $31.55 and $35.96. The current price stands at $34.40, placing the stock +9.0% above today's low and -4.3% off the high.

Yarrow Bioscience(YARW) shares are trading with a volume of 18.48K, against a daily average of 43.41K.

During the past year, Yarrow Bioscience(YARW) stock moved between $14.03 at its lowest and $46.95 at its peak.

During the past year, Yarrow Bioscience(YARW) stock moved between $14.03 at its lowest and $46.95 at its peak.

YARW News

TipRanks 5d
Yarrow Bioscience Completes VYNE Merger and Nasdaq Debut - TipRanks

...

Yarrow Bioscience Completes VYNE Merger and Nasdaq Debut - TipRanks
TipRanks 7d
Yarrow closes VYNE merger, initiates dosing in Phase 2a/2b YB-101 trial

Yarrow Bioscience (YARW) announced the completion of its merger with VYNE Therapeutics (VYNE) and the previously announced private financings totaling approxima...

People also own

Based on the portfolios of people who own YARW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.